Recent Updates
Recently added Catalysts
ESTA Positive Sentiment

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

Monday, October 19, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Establishment Labs Holdings Inc. will announce its financial results for Q3 2026 on October 29, 2026. The announcement will occur before market opening, followed by a conference call at 8:30 AM ET. This event highlights the company's ongoing commitment to transparency and investor relations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Establishment Labs is committed to women's health and wellness.
  • The upcoming financial results may indicate positive growth.
  • The company is proactive in communicating with investors.

Full Press Release Details

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2026, before the market opens on Thursday, October 29, 2026, and will host a conference call at 8:30 AM ET that day to discuss those results.To participate in the conference call, Dial: (+1) 877-407-8037 (US

Frequently Asked Questions

When will Establishment Labs announce its Q3 2026 results?

Establishment Labs will announce its Q3 2026 financial results on October 29, 2026.

What time is the conference call for Q3 results?

The conference call to discuss Q3 results will be held at 8:30 AM ET.

How can I participate in the conference call?

To participate in the conference call, dial (+1) 877-407-8037.

What is the focus of Establishment Labs?

Establishment Labs focuses on improving women's health and wellness, particularly in breast aesthetics and reconstruction.

ShareAdd on Google
Tags: ESTA Establishment Labs financial results Q3 2026 women's health NASDAQ: ESTA
Last updated: Oct 19, 2026

Biotech snapshot

Cash runway
$71M liquidity · $6M/mo burn
~11 mo
Medium dilution risk